Chapter Overview

This chapter discusses recent trends in regulatory guidance. The rules and guidelines have developed over time due to new threats or requirements. For example, the need for a robust mechanism for consumers and patients to trust their medicines' authenticity led to the DSCSA and the falsified medicines directive.